182 related articles for article (PubMed ID: 31899687)
1. PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress.
Chen X; Cao X; Xiao W; Li B; Xue Q
Aging (Albany NY); 2020 Jan; 12(1):122-137. PubMed ID: 31899687
[TBL] [Abstract][Full Text] [Related]
2. ROS‑mediated hypomethylation of PRDX5 promotes STAT3 binding and activates the Nrf2 signaling pathway in NSCLC.
Cao X; Chen XM; Xiao WZ; Li B; Zhang B; Wu Q; Xue Q
Int J Mol Med; 2021 Feb; 47(2):573-582. PubMed ID: 33416106
[TBL] [Abstract][Full Text] [Related]
3. The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models.
Qian S; Fang Y; Yao C; Wang Y; Zhang Z; Wang X; Gao J; Feng Y; Sun L; Zou R; Zhou G; Ye J; Xia R; Xia H
Oncol Res; 2022; 30(2):53-64. PubMed ID: 37305326
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 promotes progression of non-small cell lung cancer through activating autophagy.
Wang J; Liu Z; Hu T; Han L; Yu S; Yao Y; Ruan Z; Tian T; Huang T; Wang M; Jing L; Nan K; Liang X
Cell Cycle; 2017 Jun; 16(11):1053-1062. PubMed ID: 28402166
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells.
Zhao Q; Mao A; Yan J; Sun C; Di C; Zhou X; Li H; Guo R; Zhang H
Int J Oncol; 2016 Feb; 48(2):765-73. PubMed ID: 26691854
[TBL] [Abstract][Full Text] [Related]
6. Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer.
Tong YH; Zhang B; Yan YY; Fan Y; Yu JW; Kong SS; Zhang D; Fang L; Su D; Lin NM
Oncotarget; 2017 Jul; 8(28):45750-45758. PubMed ID: 28501854
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 mediates redox adaptation in NOX4-overexpressed non-small cell lung cancer cells.
Wu Q; Yao B; Li N; Ma L; Deng Y; Yang Y; Zeng C; Yang Z; Liu B
Exp Cell Res; 2017 Mar; 352(2):245-254. PubMed ID: 28196727
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
10. Organophosphate-pesticides induced survival mechanisms and APE1-mediated Nrf2 regulation in non-small-cell lung cancer cells.
Thakur S; Sarkar B; Dhiman M; Mantha AK
J Biochem Mol Toxicol; 2021 Feb; 35(2):e22640. PubMed ID: 33078895
[TBL] [Abstract][Full Text] [Related]
11. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotective Effect of Makgeolli Lees on Paraquat Induced Oxidative Stress in A549 Cells via Activation of NRF2 and Antioxidant Genes.
Jeon M; Rahman N; Kim YS
J Microbiol Biotechnol; 2016 Feb; 26(2):277-86. PubMed ID: 26597533
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of the human peroxiredoxin V gene contributes to protection of the genome from oxidative DNA lesions and to suppression of transcription of noncoding DNA.
Kropotov A; Serikov V; Suh J; Smirnova A; Bashkirov V; Zhivotovsky B; Tomilin N
FEBS J; 2006 Jun; 273(12):2607-17. PubMed ID: 16817890
[TBL] [Abstract][Full Text] [Related]
14. Spatial Analysis of NQO1 in Non-Small Cell Lung Cancer Shows Its Expression Is Independent of NRF1 and NRF2 in the Tumor Microenvironment.
Kaghazchi B; Um IH; Elshani M; Read OJ; Harrison DJ
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36359002
[TBL] [Abstract][Full Text] [Related]
15. Association between 18F-FDG uptake in PET/CT, Nrf2, and NQO1 expression and their prognostic significance in non-small cell lung cancer.
Park SY; Lee SJ; Han JH; Koh YW
Neoplasma; 2019 Jul; 66(4):619-626. PubMed ID: 30868898
[TBL] [Abstract][Full Text] [Related]
16. Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
Chian S; Thapa R; Chi Z; Wang XJ; Tang X
Biochem Biophys Res Commun; 2014 May; 447(4):602-8. PubMed ID: 24747074
[TBL] [Abstract][Full Text] [Related]
17. Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway.
Miyamoto N; Izumi H; Miyamoto R; Kondo H; Tawara A; Sasaguri Y; Kohno K
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1055-63. PubMed ID: 21051700
[TBL] [Abstract][Full Text] [Related]
18. Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway.
Yu C; Jiao Y; Xue J; Zhang Q; Yang H; Xing L; Chen G; Wu J; Zhang S; Zhu W; Cao J
Int J Biol Sci; 2017; 13(12):1560-1569. PubMed ID: 29230104
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effects of esculetin against oxidative stress are associated with the upregulation of Nrf2-mediated NQO1 expression via the activation of the ERK pathway.
Han MH; Park C; Lee DS; Hong SH; Choi IW; Kim GY; Choi SH; Shim JH; Chae JI; Yoo YH; Choi YH
Int J Mol Med; 2017 Feb; 39(2):380-386. PubMed ID: 28000844
[TBL] [Abstract][Full Text] [Related]
20. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS.
Kanno T; Tanaka K; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Hirayama N; Ikeda JE
Free Radic Biol Med; 2012 Dec; 53(11):2028-42. PubMed ID: 23000247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
